- Home
- CCEL vs ATCH Comparison
CCEL vs ATCH Comparison
Compare CCEL & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- ATCH
- Stock Information
- Founded
- CCEL 1989
- ATCH 2022
- Country
- CCEL United States
- ATCH United States
- Employees
- CCEL N/A
- ATCH N/A
- Industry
- CCEL Managed Health Care
- ATCH
- Sector
- CCEL Health Care
- ATCH
- Exchange
- CCEL Nasdaq
- ATCH Nasdaq
- Market Cap
- CCEL 35.8M
- ATCH 39.9M
- IPO Year
- CCEL 1997
- ATCH N/A
- Fundamental
- Price
- CCEL $4.30
- ATCH $0.30
- Analyst Decision
- CCEL Hold
- ATCH
- Analyst Count
- CCEL 1
- ATCH 0
- Target Price
- CCEL N/A
- ATCH N/A
- AVG Volume (30 Days)
- CCEL 4.3K
- ATCH 5.9M
- Earning Date
- CCEL 10-15-2025
- ATCH 11-14-2025
- Dividend Yield
- CCEL 9.30%
- ATCH N/A
- EPS Growth
- CCEL N/A
- ATCH N/A
- EPS
- CCEL N/A
- ATCH N/A
- Revenue
- CCEL $31,747,500.00
- ATCH $12,303,120.00
- Revenue This Year
- CCEL $0.30
- ATCH N/A
- Revenue Next Year
- CCEL N/A
- ATCH N/A
- P/E Ratio
- CCEL N/A
- ATCH N/A
- Revenue Growth
- CCEL N/A
- ATCH 80.78
- 52 Week Low
- CCEL $4.00
- ATCH $0.14
- 52 Week High
- CCEL $9.10
- ATCH $16.14
- Technical
- Relative Strength Index (RSI)
- CCEL 51.29
- ATCH 45.31
- Support Level
- CCEL $4.04
- ATCH $0.25
- Resistance Level
- CCEL $4.45
- ATCH $0.32
- Average True Range (ATR)
- CCEL 0.13
- ATCH 0.03
- MACD
- CCEL 0.03
- ATCH 0.00
- Stochastic Oscillator
- CCEL 67.26
- ATCH 51.32
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.